The AVANTI Study

Step Up and Be Part of Primary Hypothyroidism Research

What Is Primary Hypothyroidism?

The thyroid is a small, butterfly-shaped gland in the front of the neck that makes thyroid hormones (T4 and T3) that control the way the body uses energy. With hypothyroidism, or underactive thyroid, the thyroid gland does not produce enough thyroid hormones, which can lead to fatigue, weight gain, cold sensitivity, dry skin, and hair loss as well as neurological symptoms that can affect memory and mood.

What Is the AVANTI Study?

The purpose of the AVANTI Study is to evaluate if an investigational medicine is safe and effective in the treatment of primary hypothyroidism. The study will compare the effect of the investigational medicine on primary hypothyroidism and its safety with Synthetic Drug T4 (Levothyroxine).

You may qualify for the AVANTI Study if you:

– Are 18 – 75 years of age
– Have been diagnosed with primary hypothyroidism for at least 12 months
– Have been on continuous thyroid replacement therapy with an FDA approved dose of synthetic T4 for at least 12 months, and at    a stable dose for at least 3 months
– Have a BMI between 18 and 40
– Meet additional study criteria

If you qualify, investigational study medication(s) and care will be provided at no cost to you.

 For more information call 

(904) 730-0166 

Or sign up below, and our friendly staff will call you!  

Adult Acne Vaccine Research 

Acne vulgaris is one of the few diseases that is visible on our skin. A rogue strain of C. acnes bacteria can cause fluid to build-up in the skin, causing inflammation. Despite treatments dating back to ancient Egypt, most adolescents and nearly half of adults in the U.S. experience acne. Current treatments fail to provide a cure and effective prevention for acne, largely due to a decades-long stagnation of new medical treatments.  

To address this lack of progress, Jacksonville Center for Clinical Research is conducting a clinical research study. We are evaluating an investigational vaccine targeting the acne-causing strain of C. acnes bacteria for its ability to treat moderate to severe acne. 

 You may be eligible to participate if you: 

• Are 18-45 years old 
• Have a diagnosis of moderate to severe acne vulgaris 

There are additional criteria to meet to qualify for this study. Volunteers who qualify for our study will receive study-related vaccine (or placebo) & medical exams at no cost, and a stipend for time and travel. No health insurance is required to participate. 

 For more information call 

(904) 730-0166 

Or sign up below, and our friendly staff will call you!  

The Eclipse Trial is evaluating an investigational vaccine to protect against EBV and
infectious mononucleosis (mono) in participants ages 12 to 17, and you or your child
may be able to take part.

All participants will receive EBV testing and results at no cost.
Compensation for trial-related time will be provided.

For more information call

(904) 730-0166

Or sign up below, and our friendly staff will call you!